SpeculatingStocks Inside Header
Stocks, Picks, Data, Articles, Analysis at SpeculatingStocks.com
 
 
   
   
  Tuesday, May 14: Nanosphere has a hot product on their hands with "Verigene" blood testing system.  
 
     
 

August 2, 2005

SpeculatingStocks.com Stock Pick: Transmeta Corporation (TMTA)

Stock Price: $0.93 (long-term strong buy)


Transmeta Corporation designs, develops and sells x86-compatible, software-based microprocessors. Their microprocessors deliver a balance of low power consumption, high performance, low cost and small size suited for diverse computing platforms.

On Friday, July 8th the company announced that they expect to be cash flow positive for the second quarter. This development comes after auditors doubted if Transmeta could even continue on as a going concern. TMTA is expected to release earnings within the next few days after substantially reducing their cash burn rate.

Now, that Transmeta has accomplished their first goal, we belive they will move onto bigger and better things as they continue their momentum. TMTA needs to retain listing on the Nasdaq by reaching and staying above $1.00, it appears this is likely.

SpeculatingStocks.com Target Price: We expect TMTA to reach $1.50 within the next 2-4 months.

 
     
 
Stocks, Picks, Data, Articles, Analysis at SpeculatingStocks.com | Copyright © 2004 - 2013 SpeculatingStocks.com, Inc.